Iris Stroot

Iris Stroot is a researcher focusing on gynecological oncology and genetic pathogenic variants. Her work primarily investigates the outcomes and prevalence of high-grade serous carcinoma in BRCA1/2 germline pathogenic variant carriers, particularly after risk-reducing salpingo-oophorectomy. She collaborates with the HEBON Investigators and contributes to academic peer-reviewed journals.

• Research Interests: BRCA1/2 mutations, preventive oncology, radiologic diagnosis, and sarcopenia in menopausal women.
• Key Trends: Studies emphasize clinical outcomes, surgical interventions, and cost-effectiveness of imaging techniques.